Paper Details

  1. Home
  2. Paper Details

Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis.

Author: BruynG A, GeisG S, Melo GomesJ A, RothS H, WoodsE M, ZeehJ

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Diclofenac/misoprostol at twice daily dosing is associated with significantly fewer gastroduodenal ulcers than either piroxicam or naproxen. The efficacy of diclofenac/misoprostol in treating the signs and symptoms of osteoarthritis is at least comparable to that of piroxicam and naproxen.
Paper Details　
Original Abstract of the Article :
OBJECTIVES: To compare the efficacy and gastroduodenal safety of a fixed-dose combination of diclofenac sodium 50 mg and misoprostol 200 micrograms twice daily with those of piroxicam 10 mg twice daily and naproxen 375 mg twice daily in patients with osteoarthritis. METHODS: A 4 week, randomised, d...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1136/ard.52.12.881

データ提供：米国国立医学図書館（NLM）

Diclofenac/Misoprostol: A Safer Option for Osteoarthritis

Osteoarthritis (OA) is a common condition affecting joints, often causing pain and inflammation. This research compares the efficacy and gastroduodenal safety of diclofenac/misoprostol, a combination medication, with two other non-steroidal anti-inflammatory drugs (NSAIDs), piroxicam and naproxen, in patients with OA. The study found that diclofenac/misoprostol was associated with significantly fewer gastroduodenal ulcers compared to the other NSAIDs, suggesting a safer option for patients with OA who require continuous NSAID therapy.

Navigating the Desert of Osteoarthritis

This research explores the challenges of managing osteoarthritis (OA), a condition that can make everyday activities difficult. Imagine traversing a vast and unforgiving desert, where the terrain is uneven and discomfort is constant. This research explores the potential benefits of different medications for managing OA, finding safer and more effective options for navigating this challenging landscape.

Finding a Safe Oasis: A Comparison of Medications

This research provides a valuable comparison of different medications for managing osteoarthritis (OA). The study found that diclofenac/misoprostol, a combination medication, was associated with significantly fewer gastroduodenal ulcers compared to other NSAIDs. It's like finding a safe oasis in the desert of OA, where individuals can find relief from pain and inflammation with minimal risk of adverse effects.

Dr.Camel's Conclusion

This research offers valuable insights into the management of osteoarthritis (OA), highlighting the potential benefits of diclofenac/misoprostol as a safer option for patients requiring continuous NSAID therapy. The study's findings provide a beacon of hope for individuals seeking relief from the pain and discomfort of OA while minimizing the risk of gastroduodenal complications. This research, like a skilled camel guide navigating the desert of OA, helps healthcare professionals find the most effective and safest treatment options for their patients.
Date :
  1. Date Completed 1994-03-17
  2. Date Revised 2019-05-03
Further Info :

Pubmed ID

8311540

DOI: Digital Object Identifier

10.1136/ard.52.12.881

Related Literature

Article Analysis
・Effects of diclofenac and misoprostol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.